|
GFM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.6358005495174E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.60180030034974E-10 |
| Normal-vs-Stage2 |
9.474100E-02 |
| Normal-vs-Stage3 |
1.31579969142592E-10 |
| Normal-vs-Stage4 |
1.95989890983128E-11 |
| Stage1-vs-Stage2 |
8.556000E-03 |
| Stage1-vs-Stage3 |
1.559970E-01 |
| Stage1-vs-Stage4 |
1.833560E-02 |
| Stage2-vs-Stage3 |
1.364140E-03 |
| Stage2-vs-Stage4 |
1.402360E-04 |
| Stage3-vs-Stage4 |
2.392600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.50821585723315E-12 |
| Normal-vs-AfricanAmerican |
1.72219999999834E-05 |
| Normal-vs-Asian |
3.34660000045339E-07 |
| Caucasian-vs-AfricanAmerican |
8.905800E-01 |
| Caucasian-vs-Asian |
7.976400E-01 |
| AfricanAmerican-vs-Asian |
9.608600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.34739996937583E-09 |
| Normal-vs-Female |
2.50959997227795E-09 |
| Male-vs-Female |
1.918770E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.32490043777989E-10 |
| Normal-vs-Age(41-60Yrs) |
6.12759998297463E-09 |
| Normal-vs-Age(61-80Yrs) |
1.98709999998936E-06 |
| Normal-vs-Age(81-100Yrs) |
6.276200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.601200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.597800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.751800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.680800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.768000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.938600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.323830E-01 |
| Classical-VS-Follicular |
9.037800E-04 |
| Classical-VS-Other |
2.369000E-01 |
| Classical-VS-Normal |
9.20752363242627E-12 |
| Tall-VS-Follicular |
9.85199999999908E-05 |
| Tall-VS-Other |
6.356400E-01 |
| Tall-VS-Normal |
3.62789998042956E-09 |
| Follicular-VS-Other |
6.081700E-02 |
| Follicular-VS-Normal |
1.459590E-02 |
| Other-VS-Normal |
2.189800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.11209999489981E-08 |
| Normal-vs-N1 |
1.41640033035628E-11 |
| N0-vs-N1 |
7.101400E-03 |
|
|
